Penserra Capital Management LLC - SYROS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$6,000
-14.3%
1,415
+0.4%
0.00%–
Q2 2021$7,000
-30.0%
1,410
+1.1%
0.00%–
Q1 2021$10,000
-9.1%
1,395
+32.9%
0.00%–
Q4 2020$11,000
+266.7%
1,050
+169.2%
0.00%–
Q3 2020$3,000–390–0.00%–
 Download
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 881,450$5,677,0001.32%
IFP Advisors, Inc 50$1,0000.00%
Ten Capital Wealth Advisors, LLC 219$1,0000.00%
View complete list of SYROS PHARMACEUTICALS INC shareholders